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Background: Genome-wide microarray expression is a rich source of functional genomic data. We examined
evidence for differences in expression from peripheral blood mononuclear cells between individuals, examined
some of factors that may be responsible and provide recommendations for analysis.
Methods: A total of 643 individuals from 17 large Mexican American pedigrees had microarray gene expression
data generated from peripheral blood mononuclear cells. This data has previously been used to map cis- and
trans-expression quantitative trait loci using genome-wide linkage analysis. We estimated both principal
components and cell proportions in these data, and tested them for association with clinical factors to provide
insight into causes of variation in gene expression between individuals.
Results: We identified that there were highly significant differences in the second principal component of gene
expression between pedigrees, with 3 pedigrees being outliers. The estimated cell proportions identified 1
individual who was a gross outlier, as well as pedigrees that differed from others in their estimated proportions of
helper and cytotoxic T cells.
Conclusions: These phenomena could be from either pedigree-specific genetic variation, technical artefacts, or
clinical factors. Incorporating factors that influence gene expression into genetic analysis, and exclusion of outliers
could improve the power of genetic mapping of expression traits.Background
Functional genomics studies face many challenges, in-
cluding defining the cell type(s) of study, and their rela-
tive proportions. In the Genetic Analysis Workshop 19
(GAW19) Mexican American family data [1], microarray
gene expression data were obtained from 647 individuals
after peripheral blood samples were subjected to cell
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This is expected to remove eosinophils, neutrophils, and
basophils, leaving T-, B-, NK-lymphocytes and mono-
cytes. The proportions of T- and B-lymphocytes and
monocytes vary between individuals, are heritable, and
genome-wide association studies have identified numer-
ous loci for them (eg, Nalls et al. [3]). Gene expression
analysis performed on mixtures of cell types can poten-
tially be confounded by heterogeneity of cell types. Simi-
lar observations have been made for epigenetic studies
using DNA methylation [4].le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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We centered and scaled the gene expression data for
each probe to have mean 0 and variance 1. Using a sin-
gular value decomposition of the 643 × 20,634 scaled
matrix, we found the loadings for the principal compo-
nents (PCs) and the proportion of total variability
accounted for by each (R prcomp). The expression PCs
were then used as the response variable to examine the
relationship between them and covariates. Specifically,
for each of the first 3 PCs we tested for their association
with age, gender, medication, blood pressure (BP), hyper-
tension, and smoking status, all measured at visit 1, as
well as with pedigree number, one at a time. We also fit-
ted the models for age stratified by gender and, finally, a
model with age, gender, and their interaction along with
pedigree number. BP measures were missing for 12 indi-
viduals at visit 1. Treated systolic blood pressure (SBP)
and diastolic blood pressure (DBP) values had 10 and
5 mmHg added to their measured values, respectively, as
suggested previously [5]. Statistical significance was de-
fined as p < 0.05.
Estimation of the proportion of cytotoxic (CD8+),
helper (CD4+) T-, and B-lymphocytes and monocytes
in peripheral blood mononuclear cells from each indi-
vidual was achieved by identifying gene expression
signatures for different cell types from HaemAtlas [6]
using 4879 probes that overlapped with the GAW19
data, and the quadratic programming algorithm of
Gong et al. [7] as implemented in the R package Cell-
Mix [8]. Examination of differences in each of the cell
proportions between pedigrees was estimated using
analysis of variance.Results
Descriptive statistics
Of the 647 individuals with gene expression data, 4 did
not appear in the phenotype or pedigree files, leaving
643 for analysis. Of those with expression data, at visit 1,
the mean age was 39.6 years (SD = 16.9), with 269 males
and 374 females. There were 497 nonsmokers, 133
smokers, and 13 with missing smoking data (coded as a
third category in the analysis). A total of 123 had hyper-
tension (SBP >140 mmHg or DBP >90 mmHg or on
anti-BP medication), 513 did not, with 7 missing. In
addition, 631 individuals had BP measurements (12
missing). Of those with BP data, 559 reported they did
not take BP medication, 65 reported taking medications,
and 7 were unknown. We only adjusted the 65 individ-
uals who reported taking medications (SBP +10 mmHg,
DBP +5 mmHg). The mean unadjusted SBP was
121.9 mmHg (122.9 adjusted), SD = 19.4 (20.9 adjusted).
The mean unadjusted DBP was 71.2 mmHg (71.8 ad-
justed), SD = 9.97 (10.5 adjusted).Association of gene expression principal components
with covariates
Gene expression data was available for individuals from
17 pedigrees (Table 1). PC analysis identified 26 PCs that
account for 50 % of the original variability (Fig. 1). The
first 3 PCs account for approximately 12, 5, and 4 %, re-
spectively, of the variance in gene expression with the
first 10 PCs accounting for the majority of the variation.
For the first 3 PCs, there was only a nominally signifi-
cant association of PC3 with age (Table 2), but not for
PC1 or PC2. Gender was not significantly associated
with any of the 3 PCs. There was no significant associ-
ation of age with first 3 PCs in males (p > 0.05), but there
was a borderline association within females for PC3, p =
0.03. Models including age, gender and their interaction
did not identify significant interactions for any of the
first 3 PCs. There does appear to be a slight relationship
between BP medication and the first and third PCs
(Table 2). Medicated individuals had lower values of
these 2 PCs. A logistic regression of medication as the
response with the first 3 PCs as predictors also showed
that the probability of medication decreases as the first
(p = 0.015) and third (p = 0.025) PCs increase, but there
is no effect on the probability of medication for the sec-
ond PC (p = 0.74). There was no significant association
of SBP with each of the 3 PCs, nominal evidence for as-
sociation of DBP with PC3. Hypertension status was as-
sociated with PC1 (p = 0.016, Table 2).
There was no significant association between pedigree
number and PC1 or PC3 (p = 0.091 and 0.26, respect-
ively). In contrast, there was a highly significant associ-
ation between pedigree number and PC2 (R2 = 0.19, F =
9.137, P < 2:2 × 10−16). Specifically, 3 pedigrees (5, 6, and
8) had significantly different PC2 values (see Table 1;
Figs. 2 and 3). Inclusion of age, gender and the inter-
action between age and gender did not appreciably alter
the findings, with pedigrees 5, 6, and 8 still showing sig-
nificantly different PC2 values (Fig. 3). PCs were also es-
timated from unrelated individuals (using data available
from Genetic Analysis Workshop 18), and their weights
were applied to the remaining subjects, but the conclu-
sions were not altered.
Estimated cell proportions
The estimated proportion of granulocytes and natural
killer cells was zero for all individuals. The proportion
of: monocytes ranged from zero to 0.0997 (mean =
0.0199, SD = 0.018); B lymphocytes ranged from 0.311 to
0.387 (mean = 0.348, SD = 0.011); Tc lymphocytes ranged
from 0.275 to 0.535 (mean = 0.341, SD = 0.031); and Th
lymphocytes ranged from 0.108 to 0.375 (mean = 0.291,
SD = 0.030). The association of pedigree with cell pro-
portions were all nominally significant but only the Tc
and Th lymphocytes survived Bonferroni correction for





PC1 PC2 Cytotoxic T cells Helper T cells
B SE P B SE P B SE P B SE P
2 67 −15.3 6.1 0.013 −6.3 3.6 0.083 −4.6 e-3 5.2 e-3 0.37 7.7e-3 5.1 e-3 0.14
3 44 −10.7 7.5 0.16 −3.9 4.5 0.39 −1.8 e-2 5.9 e-3 0.0021 2.0e-2 5.8 e-3 6.6e-4
4 39 8.7 8.0 0.28 14.9 4.7 0.0018 −1.0 e-2 6.3 e-3 0.12 9.5e-3 6.2 e-3 0.13
5 55 −0.4 6.7 0.94 −18.4 4.0 5.6e-6 −1.6 e-2 5.7 e-3 0.0046 1.7e-2 5.6 e-3 0.0022
6 45 1.6 7.4 0.83 −14.9 4.4 8.6e-4 −1.4 e-2 6.0 e-3 0.019 1.4e-2 6.0 e-3 0.015
8 62 −1.5 6.3 0.81 33.8 3.7 <2e-16 1.3 e-3 5.6 e-3 0.81 −2.5e-3 5.5e-3 0.64
10 49 −6.8 7.1 0.34 −4.8 4.2 0.26 −6.4 e-3 5.6 e-3 0.26 6.5e-3 5.6e-3 0.24
14 30 −10.5 9.1 0.25 2.9 5.4 0.59 −1.6 e-2 6.7 e-3 0.015 1.5e-2 6.6e-3 0.019
15 27 17.1 9.6 0.076 3.0 5.7 0.59 −1.8 e-2 7.0 e-3 0.0086 1.6 e-2 6.9 e-3 0.019
16 38 −4.3 8.1 0.60 −3.6 4.8 0.45 −2.9 e-3 6.1 e-3 0.63 3.3 e-3 6.0 e-3 0.58
17 29 8.6 9.3 0.36 4.2 5.5 0.44 −6.7 e-3 6.7 e-3 0.32 1.3 e-3 6.6 e-3 0.84
20 26 −1.6 9.8 0.86 −7.9 5.8 0.18 7.0 e-4 7.2 e-3 0.92 7.4 e-4 7.1 e-3 0.92
21 30 2.5 9.1 0.78 2.5 5.4 0.63 −1.1 e-2 6.7 e-3 0.084 9.5 e-3 6.6 e-3 0.15
23 28 4.4 9.5 0.64 −13.3 5.6 0.018 1.0 e-3 6.8 e-3 0.88 7.5 e-3 6.7 e-3 0.27
25 22 4.9 10.7 0.65 −4.1 6.3 0.52 5.3 e-3 7.6 e-3 0.48 −3.4 e-4 7.4 e-3 0.96
27 31 24.1 9.0 0.0076 15.0 5.3 0.0051 −2.6 e-2 6.5 e-3 6.2e-5 2.0 e-2 6.4 e-3 0.0013
47 21 13.9 10.9 0.20 −9.1 6.5 0.16 −9.2 e-3 7.8 e-3 0.24 2.4 e-2 7.7 e-3 0.0019
Three pedigrees (7, 9, and 11) had no individuals with gene expression data. Global p = 0.091 for PC1, p < 2.2e-16 for PC2, p = 6.5e-12 for cytotoxic T-cell propor-
tion, and p = 8.5e-9 for helper T-cell proportion. Bold indicates pedigrees with significant differences at α = 0.05/17(pedigrees) level (p < 0.0029)
Table 2 Univariate associations of covariates with PCs
Predictor variable PC B(SE) T p
The Author(s) BMC Proceedings 2016, 10(Suppl 7):58 Page 93 of 4154 tests (p = 0.00012 and p = 0.00034; see Table 1). For Tc
lymphocytes the significance is driven by differences be-
tween pedigrees 27 and 3 and the rest, whereas for Th
lymphocytes it is driven primarily by differences between
pedigrees 3, 5, 27, and 47 (see Table 1 and Fig. 4). One
individual from pedigree 8 (ID# T2DG0800552) was
identified to be a gross outlier based on Tc and ThFig. 1 PC analysis of gene expression. Scree plot of the proportion
of total variability explained by the first 10 PCs of the
expression dataproportions (Fig. 4), consistent with an acute viral infec-
tion. The estimated proportion of T cytotoxic and helper
lymphocytes were significantly correlated with the first 3
PCs (Table 3), although this may be tautological, as someAge 1 −0.20 (0.12) −1.7 0.091
2 0.026 (0.077) 0.33 0.74
3 −0.15 (0.073) −2.11 0.036
Sex 1 −2.73 (4.05) −0.67 0.50
2 0.52 (2.62) 0.20 0.84
3 −0.010 (2.51) −0.04 0.97
Blood pressure medication 1 −15.7 (6.5) 2.40 0.017
2 2.46 (4.2) 0.58 0.56
3 −8.87 (4.10) −2.19 0.029
SBP 1 −0.18 (0.10) −1.91 0.057
2 0.033 (0.063) 0.52 0.60
3 −0.12 (0.060) −1.95 0.052
DBP 1 −0.33 (0.19) −1.72 0.087
2 −0.052 (0.13) −0.42 0.68
3 −0.30 (0.12) −2.54 0.011
Hypertension 1 −12.2 (5.08) −2.41 0.016
2 1.93 (3.30) 0.59 0.56
3 −5.87 (3.14) −1.87 0.062
Fig. 2 Scatterplot of PC1 vs PC2. Pedigrees 5, 6, and 8
are highlighted
Fig. 4 Scatterplot of estimated proportion of cytotoxic (y-axis) and
helper (x-axis) T lymphocytes, with 3 outlier pedigrees highlighted
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both measures. All cell counts (0.34 to 0.44) and the first
5 PCs (0.19 to 0.54) were significantly heritable (SOLAR
[Sequential Oligogenic Linkage Analysis Routines] v4.1.3
for windows), with adjustment for age, sex, and their
interaction (data not shown).Fig. 3 Box-and-whisker plots of the second PC for each of the
individuals from the 17 pedigrees. The edges of the boxes are the
upper and lower quartiles and the whiskers extend to the most
extreme points within 1.5 times the interquartile range of the closest
quartile. Points outside these limits are plotted individually. The
location of the median in each pedigree is indicated as the thick
line across the box. The horizontal line across all boxes is at 0, the
overall mean of the PCDiscussion
A large number of PCs are detected in the microarray
gene expression data. Although age, sex, and other clin-
ical factors were not associated with the 3 first PCs,
pedigree number was highly significantly associated with
PC2, with 3 pedigrees being gross outliers. Pedigree dif-
ferences in PC2 could be from genetic variation that is
related to pedigree membership that is influencing gene
expression. Alternatively, it could be a result of pedigree
differences in technical procedures or in the proportion
of different cell types in those subjected to analysis. Cell
proportions were estimated and 1 individual was shown
to be a gross outlier and power may be improved by ex-
clusion of such subjects. An overlapping set of 2 and 4
pedigrees had significant differences in the estimated
proportion of Tc and Th lymphocytes, respectively. The
analysis did not take pedigree structure into account, po-
tentially leading to inflated type 1 error.
In general, identification of factors that are associated
with differences between individuals in functional gen-









X −0.80 −0.099 −0.29 −0.13
Th
lymphocyte
<10−16 X 0.23 0.14 0.50
PC1 0.012 3 × 10−9 X 0.082 0.024
PC2 10−13 3 × 10−4 0.04 −0.014
PC3 0.0014 <10−16 0.54 0.72 X
Coefficients are above the diagonal, p values are below the diagonal
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proportions were shown to be significantly heritable, this
could motivate mapping the loci responsible.
Conclusions
This is not the first [9, 10], nor likely the last description
of possible batch effects in functional genomic data. Ac-
cording to the description of the GAW19 expression
data, the lab method was as described in Göring et al.
[2], while the data that was distributed underwent differ-
ent processing [1], mostly focused on providing data for
probes where the “detection p value” was consistent,
with detectable expression across most individuals. It is
unlikely that such preprocessing would produce PCs that
we observed in the data.
Acknowledgements
We thank the GAW19 data providers and organizers. The GAW19 whole
genome sequence data were provided by the Type 2 Diabetes Genetic
Exploration by Next-generation sequencing in Ethnic Samples (T2D-GENES)
Consortium, which is supported by National Institutes of Health (NIH) grants
U01 DK085524, U01 DK085584, U01 DK085501, U01 DK085526, and U01
DK085545. The other genetic and phenotypic data for GAW19 were provided
by the San Antonio Family Heart Study and San Antonio Family Diabetes/
Gallbladder Study, which are supported by NIH grants P01 HL045222, R01
DK047482, and R01 DK053889. The Genetic Analysis Workshop is supported
by NIH grant R01 GM031575.
Declarations
This article has been published as part of BMC Proceedings Volume 10
Supplement 7, 2016: Genetic Analysis Workshop 19: Sequence, Blood
Pressure and Expression Data. Summary articles. The full contents of the
supplement are available online at http://bmcproc.biomedcentral.com/
articles/supplements/volume-10-supplement-7. Publication of the
proceedings of Genetic Analysis Workshop 19 was supported by National
Institutes of Health grant R01 GM031575.
Authors’ contributions
ADP conceived of the study, and participated in its design and coordination
and helped to draft the manuscript. MG performed the statistical analysis.
AJC overlooked the data analysis and contributed to the manuscript. All
authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Author details
1Department of Mathematics and Statistics, McMaster University, Hamilton,
ON L8S 4 K1, Canada. 2Genetics and Genome Biology Program, The Hospital
for Sick Children Research Institute, Toronto, ON M5G 0A4, Canada. 3Dalla
Lana School of Public Health, University of Toronto, Toronto, ON M5G 0A4,
Canada.
Published: 18 October 2016
References
1. Blangero J, Teslovich TM, Sim X, Almeida MA, Jun G, Dyer TD, Johnson M,
Peralta JM, Manning AK, Wood AR, et al. Omics squared: human genomic,
transcriptomic, and phenotypic data for Genetic Analysis Workshop 19. BMC
Proc. 2015;9 Suppl 8:S2.
2. Göring HH, Curran JE, Johnson MP, Dyer TD, Charlesworth J, Cole SA, Jowett
JB, Abraham LJ, Rainwater DL, Comuzzie AG, et al. Discovery of expression
QTLs using large-scale transcriptional profiling in human lymphocytes. Nat
Genet. 2007;39(10):1208–16.
3. Nalls MA, Couper DJ, Tanaka T, van Rooij FJ, Chen MH, Smith AV, Toniolo D,
Zakai NA, Yang Q, Greinacher A, et al. Multiple loci are associated with
white blood cell phenotypes. PLoS Genet. 2011;7(6):e1002113.4. Michels KB, Binder AM, Dedeurwaerder S, Epstein CB, Greally JM, Gut I,
Houseman EA, Izzi B, Kelsey KT, Meissner A, et al. Recommendations for the
design and analysis of epigenome-wide association studies. Nat Methods.
2013;10(10):949–55.
5. Cui JS, Hopper JL, Harrap SB. Antihypertensive treatments obscure familial
contributions to blood pressure variation. Hypertension. 2003;41(2):207–10.
6. Watkins NA, Gusnanto A, de Bono B, De S, Miranda-Saavedra D, Hardie DL,
Angenent WG, Attwood AP, Ellis PD, Erber W, et al. A HaemAtlas:
characterizing gene expression in differentiated human blood cells. Blood.
2009;113(19):e1–9.
7. Gong T, Hartmann N, Kohane IS, Brinkmann V, Staedtler F, Letzkus M,
Bongiovanni S, Szustakowski JD. Optimal deconvolution of transcriptional
profiling data using quadratic programming with application to complex
clinical blood samples. PLoS One. 2011;6(11):e27156.
8. Gaujoux R, Seoighe C. Cell Mix: a comprehensive toolbox for gene
expression deconvolution. Bioinformatics. 2013;29(17):2211–2.
9. Akey JM, Biswas S, Leek JT, Storey JD. On the design and analysis of gene
expression studies in human populations. Nat Genet. 2007;39(7):807–8.
author reply 808–809.
10. Spielman RS, Cheung VG. On the design and analysis of gene expression
studies in human populations-author reply. Nat Genet. 2007;39:808–9.•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
